<DOC>
	<DOCNO>NCT02964481</DOCNO>
	<brief_summary>The purpose study determine penetrance know probable pathogenic variant gene factor contribute penetrance population child adult United States expose Malignant Hyperthermia ( MH ) trigger agent .</brief_summary>
	<brief_title>Malignant Hyperthermia Registry Genetic Testing</brief_title>
	<detailed_description>The purpose study determine genetic mutation variant combination non-genetic factor influence risk MH child general anesthesia trigger agent develop reliable predictive MH risk algorithm . Rationale : Once factor responsible MH risk determine , possible good predict risk develop good individualization anesthetic tailor selection intravenous anesthetic , regional anesthesia avoidance trigger agent . The long-term goal tailor improve safety anesthetic clinical care reduce mortality , morbidity cost care due MH right anesthetic muscle relaxant endotracheal intubation individual child .</detailed_description>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Malignant Hyperthermia</mesh_term>
	<criteria>Any English speaking person register NAHMR positive clinical manifestation Malignant Hyperthermia Any person positive Caffeine Halothane Contracture probTest ( CHCT ) close relative person . Any person NOT positive clinical manifestation Malignant Hyperthermia Any person positive Caffeine Halothane Contracture Test ( CHCT ) NOT close relative person . NonEnglish speaking registrant exclude .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>malignant</keyword>
	<keyword>genetics</keyword>
	<keyword>RYR1</keyword>
	<keyword>CAC-NA1S</keyword>
	<keyword>hyperthermia</keyword>
</DOC>